Integrating New Technologies into Everyday Practice Management "Presentation" - Neal Patel, Mark Thompson, Candice Sonko & Alicia Davis ...

(UroToday.com) The 2024 South Central AUA annual meeting included an endourology session, featuring a presentation by Dr.

ImmunityBio Completes ANKTIVA’s Post-Approval Enrollment of the 100th Patient in BCG Unresponsive NMIBC CIS Trial and Reports a Complete Response Rate of 71% with a Durable Duration of Response ...

Medications Most Commonly Associated With Erectile Dysfunction: Evaluation of the Food and Drug Administration National Pharmacovigilance Database - Beyond the Abstract ...

Gautam Jayram discusses key updates in bladder and kidney cancer management. Topics include intermediate-risk bladder cancer, BCG-unresponsive disease, immunotherapy for muscle-invasive bladder cancer ...

There are other non-infectious IUC-related adverse effects that occur the longer an indwelling urinary catheter (IUC), particularly a transurethral IUC, is used for bladder drainage. They include ...

Sacral neuromodulation (SNM) is an effective third-line therapy for overactive bladder (OAB). COVID-19 may have a temporary negative effect on SNM function. We describe two cases of increased sensory ...

To provide a brief anatomical pathogenesis of the Working Group SUI publication recommendations. The anatomical science and surgical practice presented here formed ...

Patients Undergoing Double J Substitution with a Pigtail Suture Stent Report a Significant Decrease of Stent-Related Symptoms. Results from a Prospective Multicenter Longitudinal Trial - Beyond the ...

Bipolar TURP is regarded as the gold standard for treatment of BPH. Historically, when compared to HOLEP, bTURP has been found to have shorter operative times and is considered more efficient. We ...

Catheter related problems due to an indwelling urinary catheter (IUC) have existed as long as urinary catheters have been utilized. This section will review IUC complications: infectious complications ...

The digitization of health records and growing availability of tumour DNA sequencing provide an opportunity to study the determinants of cancer outcomes with unprecedented richness. Patient data are ...